Evidence Level:Sensitive: B - Late Trials
New
Title:
Impact of polymorphisms within genes involved in regulating DNA methylation in metastatic colorectal cancer patients enrolled in three independent, randomized, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC, and FIRE-3.
Excerpt:A total of 884 mCRC patients from six treatment arms of three independent phase III trials....IDH1 rs1437410 was suggestively associated with PFS (HR = 1.15, 95% CI 1.01 – 1.31, P = 0.034, FDR adjusted P=0.14).
Secondary therapy:FOLFIRI; FOLFOXIRI; FOLFOX
DOI:10.1016/j.ejca.2019.01.105